NEXGEL, Inc. (NASDAQ:NXGLW) Short Interest Down 91.9% in June

NEXGEL, Inc. (NASDAQ:NXGLW) saw a significant decline in short interest in June. As of June 15th, there was short interest totaling 125 shares, a decline of 91.9% from the May 31st total of 1,534 shares. Based on an average daily trading volume, of 5,691 shares, the short-interest ratio is presently 0.0 days.

NEXGEL Stock Down 10.4%

NEXGEL stock traded down $0.00 during mid-day trading on Thursday, reaching $0.02. 11,813 shares of the company were exchanged, compared to its average volume of 14,513. The business has a fifty day moving average of $0.05 and a 200 day moving average of $0.11. NEXGEL has a 12-month low of $0.02 and a 12-month high of $0.36.

About NEXGEL

NEXGEL, Inc manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name.